Literature DB >> 19578703

High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.

J Primo1, I Siqueira, M C F Nascimento, M F Oliveira, L Farre, E M Carvalho, A L Bittencourt.   

Abstract

Salvador (BA, Brazil) is an endemic area for human T-cell lymphotrophic virus type 1 (HTLV-1). The overall prevalence of HTLV-1 infection in the general population has been estimated to be 1.76%. HTLV-1 carriers may develop a variety of diseases such as adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH). IDH is a chronic and severe form of childhood exudative and infective dermatitis involving mainly the scalp, neck and ears. It has recently been observed that 30% of patients with IDH develop juvenile HAM/TSP. The replication of HTLV-1 has been reported to be greater in adult HAM/TSP patients than in asymptomatic HTLV-1 carriers. In the current study, the proviral load of 28 children and adolescents with IDH not associated with HAM/TSP was determined and the results were compared to those obtained in 28 HTLV-1 adult carriers and 28 adult patients with HAM/TSP. The proviral load in IDH patients was similar to that of patients with HAM/TSP and much higher than that found in HTLV-1 carriers. The high levels of proviral load in IDH patients were not associated with age, duration of illness, duration of breast-feeding, or activity status of the skin disease. Since proviral load is associated with neurological disability, these data support the view that IDH patients are at high risk of developing HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578703      PMCID: PMC2963476          DOI: 10.1590/s0100-879x2009005000008

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  13 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  Human T cell lymphotropic virus type I-associated infective dermatitis in Jamaica: a case report of clinical and biologic correlates.

Authors:  E M Maloney; M Hisada; P Palmer; K Brooks; E Pate; S Z Wiktor; L Lagrenade; A Manns
Journal:  Pediatr Infect Dis J       Date:  2000-06       Impact factor: 2.129

3.  Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years.

Authors:  B Hanchard; L LaGrenade; C Carberry; V Fletcher; E Williams; B Cranston; W A Blattner; A Manns
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

4.  Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children.

Authors:  L La Grenade; A Manns; V Fletcher; D Derm; C Carberry; B Hanchard; E M Maloney; B Cranston; N P Williams; R Wilks; E C Kang; W A Blattner
Journal:  Arch Dermatol       Date:  1998-04

5.  Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica.

Authors:  Elizabeth Margaret Maloney; Yoshihisa Yamano; Paul C Vanveldhuisen; Takashi Sawada; Norma Kim; Beverley Cranston; Barrie Hanchard; Steven Jacobson; Michie Hisada
Journal:  J Infect Dis       Date:  2006-07-28       Impact factor: 5.226

Review 6.  Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.

Authors:  C R Bangham; S E Hall; K J Jeffery; A M Vine; A Witkover; M A Nowak; D Wodarz; K Usuku; M Osame
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

7.  Infective dermatitis associated with the human T cell lymphotropic virus type I in Salvador, Bahia, Brazil.

Authors:  Maria de Fatima S P de Oliveira; Carlos Brites; Neide Ferraz; Paula Magalhaes; Fabricio Almeida; Achilea L Bittencourt
Journal:  Clin Infect Dis       Date:  2005-04-27       Impact factor: 9.079

8.  High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.

Authors:  A S Gabet; F Mortreux; A Talarmin; Y Plumelle; I Leclercq; A Leroy; A Gessain; E Clity; M Joubert; E Wattel
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

9.  Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.

Authors:  Janeusa Rita L Primo; Carlos Brites; Maria de Fátima S P de Oliveira; Otávio Moreno-Carvalho; Marcos Machado; Achiléa L Bittencourt
Journal:  Clin Infect Dis       Date:  2005-07-08       Impact factor: 9.079

10.  Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.

Authors:  Axelle Dehée; Raymond Césaire; Nathalie Désiré; Agnès Lézin; Olivier Bourdonné; Odile Béra; Yves Plumelle; Didier Smadja; Jean Claude Nicolas
Journal:  J Virol Methods       Date:  2002-04       Impact factor: 2.014

View more
  15 in total

1.  Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.

Authors:  Silvane Braga Santos; Paulo Oliveira; Tania Luna; Anselmo Souza; Márcia Nascimento; Isadora Siqueira; Davi Tanajura; André Luiz Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

2.  Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.

Authors:  Davi Tanajura; Néviton Castro; Paulo Oliveira; Abraão Neto; André Muniz; Natália B Carvalho; Glória Orge; Silvane Santos; Marshall J Glesby; Edgar M Carvalho
Journal:  Clin Infect Dis       Date:  2015-03-27       Impact factor: 9.079

Review 3.  Human T-cell leukemia virus-associated malignancy.

Authors:  Amanda R Panfil; Michael P Martinez; Lee Ratner; Patrick L Green
Journal:  Curr Opin Virol       Date:  2016-08-31       Impact factor: 7.090

Review 4.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

5.  Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.

Authors:  Maria Fernanda Rios Grassi; Viviana Nilla Olavarria; Ramon de Almeida Kruschewsky; Yoshihisa Yamano; Steven Jacobson; Graham P Taylor; Fabiola Martin; Bernardo Galvão-Castro
Journal:  J Clin Virol       Date:  2013-09-13       Impact factor: 3.168

6.  Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers.

Authors:  Raimundo Coutinho; Maria Fernanda Rios Grassi; Ana Beatriz Korngold; Viviana Nilla Olavarria; Bernardo Galvão-Castro; Rita Elizabeth Mascarenhas
Journal:  BMC Infect Dis       Date:  2014-08-22       Impact factor: 3.090

Review 7.  Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development.

Authors:  Jun-Ichirou Yasunaga; Masao Matsuoka
Journal:  Cancer Sci       Date:  2017-12-03       Impact factor: 6.716

8.  Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.

Authors:  Nicolas A Gillet; Lucy Cook; Daniel J Laydon; Carol Hlela; Kristien Verdonck; Carolina Alvarez; Eduardo Gotuzzo; Daniel Clark; Lourdes Farré; Achiléa Bittencourt; Becca Asquith; Graham P Taylor; Charles R M Bangham
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

9.  High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status.

Authors:  Renata Okajima; Augusto C P Oliveira; Jerusa Smid; Jorge Casseb; Jose Antonio Sanches
Journal:  PLoS Negl Trop Dis       Date:  2013-11-07

10.  Cutaneous Manifestations in HTLV-I Positive Blood Donors.

Authors:  Mohammad Javad Yazdanpanah; Masoud Maleki; Nasaibe Joneidi; Amir Reza Khalighi; Mahmoud Reza Azarpazhooh; Mohammad Khajedaluee; Farahnaz Tehranian; Majid Shahabi; Mohammad Esmaeil Khayami; Fatemeh Livani
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.